166 related articles for article (PubMed ID: 33516941)
1. Dynamic Changes to the Skeletal Muscle Proteome and Ubiquitinome Induced by the E3 Ligase, ASB2β.
Goodman CA; Davey JR; Hagg A; Parker BL; Gregorevic P
Mol Cell Proteomics; 2021; 20():100050. PubMed ID: 33516941
[TBL] [Abstract][Full Text] [Related]
2. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation.
Bello NF; Lamsoul I; Heuzé ML; Métais A; Moreaux G; Calderwood DA; Duprez D; Moog-Lutz C; Lutz PG
Cell Death Differ; 2009 Jun; 16(6):921-32. PubMed ID: 19300455
[TBL] [Abstract][Full Text] [Related]
4. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
[TBL] [Abstract][Full Text] [Related]
5. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
6. UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.
Polge C; Koulmann N; Claustre A; Jarzaguet M; Serrurier B; Combaret L; Béchet D; Bigard X; Attaix D; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():488-493. PubMed ID: 27378730
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulphide ameliorating skeletal muscle atrophy in db/db mice via Muscle RING finger 1 S-sulfhydration.
Lu F; Lu B; Zhang L; Wen J; Wang M; Zhang S; Li Q; Shu F; Sun Y; Liu N; Peng S; Zhao Y; Dong S; Zhao D; Lu F; Zhang W
J Cell Mol Med; 2020 Aug; 24(16):9362-9377. PubMed ID: 32633463
[TBL] [Abstract][Full Text] [Related]
8. A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.
Hughes DC; Goodman CA; Baehr LM; Gregorevic P; Bodine SC
Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1567-C1582. PubMed ID: 37955121
[TBL] [Abstract][Full Text] [Related]
9. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
10. Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination.
Ono T; Takada S; Kinugawa S; Tsutsui H
Exp Physiol; 2015 Sep; 100(9):1052-63. PubMed ID: 25998196
[TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.
Thottakara T; Friedrich FW; Reischmann S; Braumann S; Schlossarek S; Krämer E; Juhr D; Schlüter H; van der Velden J; Münch J; Patten M; Eschenhagen T; Moog-Lutz C; Carrier L
J Mol Cell Cardiol; 2015 Oct; 87():214-24. PubMed ID: 26343497
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in the mouse skeletal muscle proteome during denervation-induced atrophy.
Lang F; Aravamudhan S; Nolte H; Türk C; Hölper S; Müller S; Günther S; Blaauw B; Braun T; Krüger M
Dis Model Mech; 2017 Jul; 10(7):881-896. PubMed ID: 28546288
[TBL] [Abstract][Full Text] [Related]
13. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
14. Atrogin1-induced loss of aquaporin 4 in myocytes leads to skeletal muscle atrophy.
Chung SW; Kim JY; Yoon JP; Suh DW; Yeo WJ; Lee YS
Sci Rep; 2020 Aug; 10(1):14189. PubMed ID: 32843684
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
16. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
Eo H; Reed CH; Valentine RJ
Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
[TBL] [Abstract][Full Text] [Related]
17. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension.
Koncarevic A; Jackman RW; Kandarian SC
FASEB J; 2007 Feb; 21(2):427-37. PubMed ID: 17172638
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
[TBL] [Abstract][Full Text] [Related]
20. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
